BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38761749)

  • 1. Prussian blue nanoparticle-based pH-responsive self-assembly for enhanced photothermal and chemotherapy of tumors.
    Shi L; Zhu M; Long R; Wang S; Wang P; Liu Y
    J Photochem Photobiol B; 2024 Jul; 256():112938. PubMed ID: 38761749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PEGylated magnetic Prussian blue nanoparticles asa multifunctional therapeutic agent for combined targeted photothermal ablation and pH-triggered chemotherapy of tumour cells.
    Xue P; Sun L; Li Q; Zhang L; Xu Z; Li CM; Kang Y
    J Colloid Interface Sci; 2018 Jan; 509():384-394. PubMed ID: 28923735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid-modified Prussian blue/polydopamine nanoparticles as an MRI agent for use in targeted chemo/photothermal therapy.
    Lin X; Cao Y; Li J; Zheng D; Lan S; Xue Y; Yu F; Wu M; Zhu X
    Biomater Sci; 2019 Jul; 7(7):2996-3006. PubMed ID: 31111139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An in-vitro study of enzyme-responsive Prussian blue nanoparticles for combined tumor chemotherapy and photothermal therapy.
    Xue P; Cheong KK; Wu Y; Kang Y
    Colloids Surf B Biointerfaces; 2015 Jan; 125():277-83. PubMed ID: 25465756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triple stimuli-responsive ZnO quantum dots-conjugated hollow mesoporous carbon nanoplatform for NIR-induced dual model antitumor therapy.
    Feng S; Mao Y; Wang X; Zhou M; Lu H; Zhao Q; Wang S
    J Colloid Interface Sci; 2020 Feb; 559():51-64. PubMed ID: 31610305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Graphene quantum dots-gated hollow mesoporous carbon nanoplatform for targeting drug delivery and synergistic chemo-photothermal therapy.
    Fang J; Liu Y; Chen Y; Ouyang D; Yang G; Yu T
    Int J Nanomedicine; 2018; 13():5991-6007. PubMed ID: 30323587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic chemo-photothermal cancer therapy of pH-responsive polymeric nanoparticles loaded IR825 and DTX with charge-reversal property.
    Wang X; Gu Y; Li Q; Xu Y; Shi Y; Wang Z; Xia M; Li J; Wang D
    Colloids Surf B Biointerfaces; 2022 Jan; 209(Pt 2):112164. PubMed ID: 34735859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multifunctional theranostic nanosystems enabling photothermal-chemo combination therapy of triple-stimuli-responsive drug release with magnetic resonance imaging.
    Lin X; Song X; Zhang Y; Cao Y; Xue Y; Wu F; Yu F; Wu M; Zhu X
    Biomater Sci; 2020 Mar; 8(7):1875-1884. PubMed ID: 32010912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Black Phosphorus Quantum Dots Gated, Carbon-Coated Fe
    Zhang M; Wang W; Wu F; Graveran K; Zhang J; Wu C
    Chemistry; 2018 Sep; 24(49):12890-12901. PubMed ID: 29855103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Navigate-dock-activate" anti-tumor strategy: Tumor micromilieu charge-switchable, hierarchically activated nanoplatform with ultrarapid tumor-tropic accumulation for trackable photothermal/chemotherapy.
    Cherukula K; Uthaman S; Park IK
    Theranostics; 2019; 9(9):2505-2525. PubMed ID: 31131050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-targeted and multi-stimuli responsive drug delivery system for near-infrared light induced chemo-phototherapy and photoacoustic tomography.
    Feng Q; Zhang Y; Zhang W; Shan X; Yuan Y; Zhang H; Hou L; Zhang Z
    Acta Biomater; 2016 Jul; 38():129-42. PubMed ID: 27090593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and characterization of pH-responsive nanocarriers for chemo-photothermal combination therapy of acidic tumors.
    Husni P; Shin Y; Jeon H; Lee ES; Youn YS; Poon CD; Lim C; Oh KT
    J Control Release; 2023 Jul; 359():52-68. PubMed ID: 37220804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. pH-Triggered Conformational Change of Antp-Based Drug Delivery Platform for Tumor Treatment with Combined Photothermal Therapy and Chemotherapy.
    Liang P; Wang M; Zhang S; Wang J; Dai C; Quan C
    Adv Healthc Mater; 2019 Aug; 8(15):e1900306. PubMed ID: 31211520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-stimuli responsive nanosystem modified by tumor-targeted carbon dots for chemophototherapy synergistic therapy.
    Wang X; Li X; Mao Y; Wang D; Zhao Q; Wang S
    J Colloid Interface Sci; 2019 Sep; 552():639-650. PubMed ID: 31173992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-loading of photothermal agents and anticancer drugs into porous silicon nanoparticles with enhanced chemo-photothermal therapeutic efficacy to kill multidrug-resistant cancer cells.
    Xia B; Zhang Q; Shi J; Li J; Chen Z; Wang B
    Colloids Surf B Biointerfaces; 2018 Apr; 164():291-298. PubMed ID: 29413608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indocyanine green-modified hollow mesoporous Prussian blue nanoparticles loading doxorubicin for fluorescence-guided tri-modal combination therapy of cancer.
    Yang R; Hou M; Gao Y; Zhang L; Xu Z; Kang Y; Xue P
    Nanoscale; 2019 Mar; 11(12):5717-5731. PubMed ID: 30865744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Facile Construction of i-Motif DNA-Conjugated Gold Nanostars as Near-Infrared and pH Dual-Responsive Targeted Drug Delivery Systems for Combined Cancer Therapy.
    Miao D; Yu Y; Chen Y; Liu Y; Su G
    Mol Pharm; 2020 Apr; 17(4):1127-1138. PubMed ID: 32092274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly effective photothermal chemotherapy with pH-responsive polymer-coated drug-loaded melanin-like nanoparticles.
    Zhang C; Zhao X; Guo S; Lin T; Guo H
    Int J Nanomedicine; 2017; 12():1827-1840. PubMed ID: 28331308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmonic MoO
    Odda AH; Xu Y; Lin J; Wang G; Ullah N; Zeb A; Liang K; Wen LP; Xu AW
    J Mater Chem B; 2019 Mar; 7(12):2032-2042. PubMed ID: 32254807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphological transformation enhances Tumor Retention by Regulating the Self-assembly of Doxorubicin-peptide Conjugates.
    Xu L; Wang Y; Zhu C; Ren S; Shao Y; Wu L; Li W; Jia X; Hu R; Chen R; Chen Z
    Theranostics; 2020; 10(18):8162-8178. PubMed ID: 32724464
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.